首页> 美国卫生研究院文献>Journal of Renal Injury Prevention >Association of Ca×PO4 product with levels of serum C-reactive protein in regular hemodialysis patients
【2h】

Association of Ca×PO4 product with levels of serum C-reactive protein in regular hemodialysis patients

机译:常规血液透析患者中​​Ca×PO4产物与血清C反应蛋白水平的关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Introduction: Numerous studies have attempted to identify risk factors for mortality and morbidity in maintenance hemodialysis patients. In this study we sought to examine the association of the levels of serum C-reactive protein (CRP) with value of Ca×PO4 product, in stable hemodialysis patients. >Patients and Methods: Based on the severity of secondary hyperparathyroidism, patients being treated with oral active vitamin D3, calcium carbonate/Renagel tablets at various doses. Fasting serum 25-hydroxy vitamin D and intact serum parathormone and also serum blood urea nitrogen, CRP, calcium, phosphorus, alkaline phosphatase was measured. > Results: A total of 41 patients, enrolled to the study. The mean patients’ age were 46(17.6) years. The value of serum CRP of patients was 8.6 (6.6) mg/l (median 6 mg/l). The value of Ca×PO4 product was 50.5(15.5) mg2/dl2 (median: 50 mg2/dl2). In this study, a significant inverse association between Ca×PO4 product and the age of the patients was seen. A significant positive correlation of logarithm of serum CRP with Ca×PO4 product was found. >Conclusion: The result of this study, revealed the need to further attention to hyperphosphatemia in hemodialysis patients.
机译:>简介:许多研究试图确定维持性血液透析患者死亡和发病的危险因素。在这项研究中,我们试图检查稳定血液透析患者的血清C反应蛋白(CRP)水平与Ca×PO4产物的价值之间的关系。 >患者和方法:根据继发性甲状旁腺功能亢进的严重程度,患者需要口服各种剂量的口服活性维生素D3,碳酸​​钙/雷那格尔片剂。测定空腹血清25-羟基维生素D和完整血清副甲状腺激素,以及血清血尿素氮,CRP,钙,磷,碱性磷酸酶。 >结果:共有41位患者参加了研究。患者的平均年龄为46(17.6)岁。患者的血清CRP值为8.6(6.6)mg / l(中位数6 mg / l)。 Ca×PO4产物的值为50.5(15.5)mg2 / dl2(中位数:50 mg 2 / dl 2 )。在这项研究中,发现Ca×PO4产物与患者年龄之间存在显着的负相关。发现血清CRP的对数与Ca×PO4产物显着正相关。 >结论:该研究的结果表明,需要进一步注意血液透析患者的高磷酸盐血症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号